Advancing genomics and integration of multi-omics for precision oncology using quantum machine learning
Abstract
Cancer multi-omics faces challenges in handling the scale, complexity, and heterogeneity of multi-omics data, limiting progress in variant interpretation, tumor classification, and modeling cancer evolution. Quantum computing offers a new paradigm using superposition, entanglement, and quantum interference to efficiently explore vast solution spaces. This Perspective highlights how quantum algorithms-such as Quantum Support Vector Machines, Quantum Principal Component Analysis, and quantum generative models-could enhance key tasks in precision oncology, including multi-omics integration, spatial transcriptomics, and neoantigen prediction. Current technical barriers, like qubit noise and limited quantum memory, are discussed alongside strategies to connect quantum computing with biomedical research. Interdisciplinary collaboration will be essential to realizing quantum advantage in cancer multi-omics.
How strong is the evidence?
Evidence Hub reads this as a review, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- In silico toxicology protocols
- QM7-X, a comprehensive dataset of quantum-mechanical properties spanning the chemical space of small organic molecules
- Quantum Informed Machine-Learning Potentials for Molecular Dynamics Simulations of CO2's Chemisorption and Diffusion in Mg-MOF-74
- In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications
- mRNA codon optimization with quantum computers
- The computational power of the human brain
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.